【Specification】 20ml: 30mg

【Actions and Indications】 Brain protective agents (free radical scavengers). Edaravone given to patients with acute cerebral infarction can inhibit the reduction of regional cerebral blood flow around the infarction, so that the content of NAA in the brain on the 28th day after onset is significantly higher than that in the glycerol control group.

【Directions】 The administration method of this product is intravenous infusion, and attention should be paid to avoid leakage outside the blood vessels when using. Please consult your doctor for specific medication. Do not use drugs yourself.

【Manufacturer】 Sinopharm Guorui Pharmaceutical Co., Ltd